Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-013275-21Phase 4Completed
Phase 4, single-arm trial of testosterone in arteriosclerosis, insulin resistance (IR), hypoactive sexual desire disorder (HSDD) and 1 more, sponsored by Imperial College Healthcare NHS Trust. Primary endpoints: Arterial compliance and Insulin resistance. Started Sep 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-013275-21.